Madison El-Saadi
Stock Analyst at B. Riley Securities
(2.75)
# 402
Out of 5,180 analysts
15
Total ratings
57.14%
Success rate
36.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $31 | $24.68 | +25.61% | 4 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $50 → $63 | $30.40 | +107.24% | 3 | Mar 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $62.70 | +61.08% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $6.91 | +102.60% | 2 | Dec 31, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $7.25 | +410.34% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $169.02 | +5.90% | 1 | Oct 1, 2025 |
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26 → $31
Current: $24.68
Upside: +25.61%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50 → $63
Current: $30.40
Upside: +107.24%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $62.70
Upside: +61.08%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.91
Upside: +102.60%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $7.25
Upside: +410.34%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $169.02
Upside: +5.90%